Senior Manager, Strategy and Portfolio Planning

Company Summary: Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro’s main therapeutic area is Alpha-1 Antitrypsin Deficiency (AATD). Korro is based in Cambridge, Massachusetts.

We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.

• Analyze new product ideas using internal and/or external resources while working closely with the R&D team
• Communicate disease / indication market insights to relevant internal stakeholders, identifying considerations and implications for strategic decision making
• Responsible for commercial assessment of therapeutic opportunities, in collaboration with business development, finance and research, for the purpose of strategic partnerships, licenses and acquisitions (inbound and outbound)
• Continually assess the clinical and commercial value of current and emerging assets utilizing KOL and internal teams, published scientific literature, market research, syndicated reports
• Support analysis regarding target/indication selection and portfolio prioritization
• Develop product revenue forecasts and assess competitive landscape
• Support budget and tactical timelines for given products / indications
• Provide functional input to Leadership to help define and execute on strategic priorities
• Create and maintain important scientific and business relationships with key opinion leaders within specific therapeutic categories
• Identify and execute on opportunities for external collaborations with key academic, strategic partners and other entities involved in therapeutic research programs
• Represent Korro Bio at scientific meetings and conferences
• Assist teams and executives in corporate program/project planning and management
• Work with external partners and vendors to advance programs
• Support investor and partnership presentations

• MBA/Ph.D in Life Sciences or Medicine desirable
• 2-3 years of work experience in pharma/biotech/consulting with relevant experience in gene editing and rare disease highly preferred
• Strong knowledge regarding drug development and commercialization process
• Ability to interpret and synthesize pre-clinical and clinical scientific data and identify broader implications for our programs and / or specific opportunities

Benefits:  Korro offers competitive compensation, including equity-based compensation, and a comprehensive benefits package that includes medical, dental, vision, 401(k) retirement plan, life insurance, a dependent care flexible spending account and a Company-funded health savings account and free parking.